ArticleViruses2020

The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner.

Mizuki Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.